Biography
Following his BA, with Distinction, in Human Biology from Stanford University and then his MD at UCSF, Dr. Fisher completed residencies in pediatrics and neurology at the Johns Hopkins Hospital and then a fellowship in neuro-oncology at Children’s Hospital of Philadelphia and Johns Hopkins. He also obtained a master’s degree in epidemiology at Johns Hopkins University. After starting out on the faculty at Hopkins, in 1997 Dr. Fisher was recruited back to Palo Alto, where he started the pediatric neuro-oncology program at Stanford University. His clinical work and research focus on epidemiology, therapy, and late effects of childhood brain tumors and other childhood cancers. He has authored over 300 scholarly publications on these and other neurology and pediatrics topics.
Dr. Fisher is a longtime faculty member at Stanford. He was Chief of the Division of Child Neurology at Stanford for 15 years and then Interim Chair of the Department of Neurology and Neurological Sciences. Over his time at Stanford, Dr. Fisher has served as a member of the School of Medicine Admissions Committee, IRB member, Neurology Clerkship Director, Child Neurology Residency Program Director, Senior Vice Chair for Academic Affairs in Neurology, and Bing Director of the Program in Human Biology in the School of Humanities and Sciences from 2012 through 2019. He is a past recipient of multiple teaching awards, including the Arthur L. Bloomfield and Henry J. Kaiser Awards in the School of Medicine, as well as the Phi Beta Kappa Northern California Association Award for excellence in undergraduate education. He currently teaches the popular undergraduate classes “Cancer Epidemiology” and “The Human Organism” in Human Biology.
Dr. Fisher is presently the Editor-in-Chief for The Journal of Pediatrics, and past editorial board member for the Journal of Clinical Oncology, Frontiers in Pediatric Oncology, and the Journal of Neuro-Oncology. In 2021, he was elected to the COPE Council of the Committee on Publication Ethics, and he has interests in plagiarism, text-recycling, and the editorial process.
Dr. Fisher’s personal interests are his wife Joy and three grown children, along with downhill skiing, anything baseball, travel with intense picnicking, and his dogs Monkey and Mona.
Professional Summary
Education & Certifications
- Board Certification: American Board of Pediatrics, Pediatrics (1995)
- B.A., Stanford University, Human Biology (1985)
- Medical Education: University of California at San Francisco School of Medicine (1989) CA
- Internship: Johns Hopkins Hospital Pediatric Residency (1990) MD
- Residency: Johns Hopkins Hospital Pediatric Residency (1991) MD
- Residency: Johns Hopkins Neurology Residency (1994) MD
- Fellowship: Children's Hospital of Philadelphia Child Neurology (1995) PA
- Board Certification, Pediatrics, American Board of Pediatrics (1995)
- Board Certification: American Board of Psychiatry and Neurology, Neurology - Child Neurology (1998)
- Board Certification: United Council for Neurologic Subspecialties, Neuro-Oncology (2017)
Honors & Awards
- 39th Annual Henry J. Kaiser Family Foundation Award for Excellence in Clinical Teaching, Stanford School of Medicine (2007)
- 44th Annual Arthur L. Bloomfield Award, Stanford School of Medicine (2007)
- Dunlevie Family University Fellow in Undergraduate Education, Stanford University (2016 - present)
- Excellence in Teaching Award, Phi Beta Kappa Northern California Association (2021)
- Medical Staff Distinguished Service Award, Stanford Medicine Children's Health (2023)
- Undergraduate Teaching Award, Phi Beta Kappa, Beta of California, Stanford University (2020)
Administrative Appointments
- Chief, Division of Child Neurology, Department of Neurology (2008 - 2023)
- Interim Chair, Department of Neurology (2023 - 2024)
- Senior Vice Chair, Academic Affairs, Department of Neurology (2019 - 2023)
- The Bing Director, Program in Human Biology, School of Humanities and Sciences (2012 - 2019)
- Vice Chair, Child Neurology, Department of Neurology (2016 - 2023)
Publications
-
Hyperfractionated radiotherapy in the management of diffuse intrinsic brainstem tumors: When is enough enough?
Fisher, P. G., & Donaldson, S. S. (1999). Hyperfractionated radiotherapy in the management of diffuse intrinsic brainstem tumors: When is enough enough? INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 43(5), 947–949. -
Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome
Tihan, T., Fisher, P. G., Kepner, J. L., Godfraind, C., McComb, R. D., Goldthwaite, P. T., & Burger, P. C. (1999). Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 58(10), 1061–1068. -
Case study: Suprasellar germinoma presenting with psychotic and obsessive-compulsive symptoms
Mordecai, D., Shaw, R. J., Fisher, P. G., Mittelstadt, P. A., Guterman, T., & Donaldson, S. S. (2000). Case study: Suprasellar germinoma presenting with psychotic and obsessive-compulsive symptoms. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 39(1), 116–19. -
Meningeal leukemia with cerebrospinal fluid block
Fisher, P. G., & Chiello, C. (2000). Meningeal leukemia with cerebrospinal fluid block. MEDICAL AND PEDIATRIC ONCOLOGY, 34(4), 281–283. -
No responses to oral etoposide in 15 patients with recurrent brain tumors
Korones, D. N., Fisher, P. G., Cohen, K. J., & Dubowy, R. L. (2000). No responses to oral etoposide in 15 patients with recurrent brain tumors. MEDICAL AND PEDIATRIC ONCOLOGY, 35(1), 80–82. -
A clinicopathologic reappraisal of brain stem tumor classification - Identification of pilocytic astrocytoma and fibrillary astrocytoma as distinct entities
Fisher, P. G., Breiter, S. N., Carson, B. S., Wharam, M. D., Williams, J. A., Weingart, J. D., … Burger, P. C. (2000). A clinicopathologic reappraisal of brain stem tumor classification - Identification of pilocytic astrocytoma and fibrillary astrocytoma as distinct entities. CANCER, 89(7), 1569–1576. -
Management of children with metastatic spinal myxopapillary ependymoma using craniospinal irradiation
Chinn, D. M., Donaldson, S. S., Dahl, G. V., Wilson, J. D., Huhn, S. L., & Fisher, P. C. (2000). Management of children with metastatic spinal myxopapillary ependymoma using craniospinal irradiation. MEDICAL AND PEDIATRIC ONCOLOGY, 35(4), 443–45. -
Rapid deterioration of a newborn with congenital spinal cord astrocytoma
Colby, C., Rozance, P., Goodwin, T. L., & Fisher, P. G. (2001). Rapid deterioration of a newborn with congenital spinal cord astrocytoma. MEDICAL AND PEDIATRIC ONCOLOGY, 36(4), 500–502. -
Prognostic implications for gadolinium enhancement of the meninges in low-grade astrocytomas of childhood
Hurwitz, M. D., Burger, P. C., Goldthwaite, P. T., Tihan, T., Wharam, M. D., & Fisher, P. G. (2001). Prognostic implications for gadolinium enhancement of the meninges in low-grade astrocytomas of childhood. PEDIATRIC NEUROSURGERY, 34(2), 88–93. -
Visual loss caused by pseudotumor cerebri in an infant on peritoneal dialysis
Belson, A., Alcorn, D. M., Yorgin, P. D., Fisher, P. G., & Sarwal, M. (2001). Visual loss caused by pseudotumor cerebri in an infant on peritoneal dialysis. PEDIATRIC NEPHROLOGY, 16(3), 216–18. -
A guide to children with acute and chronic headaches.
Rosenblum, R. K., & Fisher, P. G. (2001). A guide to children with acute and chronic headaches. Journal of Pediatric Health Care , 15(5), 229–235. -
Weekly dosing of carboplatin increases risk of allergy in children
Yu, D. Y., Dahl, G. V. H., Shames, R. S., & Fisher, P. G. (2001). Weekly dosing of carboplatin increases risk of allergy in children. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 23(6), 349–352. -
Daily low-dose carboplatin as a radiation sensitizer for newly diagnosed malignant glioma
Peterson, K., Harsh, G., Fisher, P. G., Adler, J., & Le, Q. (2001). Daily low-dose carboplatin as a radiation sensitizer for newly diagnosed malignant glioma. JOURNAL OF NEURO-ONCOLOGY, 53(1), 27–32. -
Surveillance neuroimaging to detect relapse in childhood brain tumors: A pediatric oncology group study
Minn, A. Y., Pollock, B. H., Garzarella, L., Dahl, G. V., Kun, L. E., Ducore, J. M., … Fisher, P. G. (2001). Surveillance neuroimaging to detect relapse in childhood brain tumors: A pediatric oncology group study. JOURNAL OF CLINICAL ONCOLOGY, 19(21), 4135–4140. -
Childhood cerebellar hemangioblastoma does not predict germline or somatic mutations in the von Hippel-Landau tumor suppressor gene
Fisher, P. G., Tontiplaphol, A., Pearlman, E. M., Duffner, P. K., Hyder, D. J., Stolle, C. A., … Zhuang, Z. P. (2002). Childhood cerebellar hemangioblastoma does not predict germline or somatic mutations in the von Hippel-Landau tumor suppressor gene. ANNALS OF NEUROLOGY, 51(2), 257–60. -
Intrathecal thiotepa: Reappraisal of an established therapy
Fisher, P. G., Kadan-Lottick, N. S., & Korones, D. N. (2002). Intrathecal thiotepa: Reappraisal of an established therapy. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 24(4), 274–78. -
Radiation therapy for intracranial germ cell tumors
Haas-Kogan, D. A., Missett, B. T., Wara, W. M., Donaldson, S. S., Lamborn, K. R., Prados, M. D., … Le, Q. T. (2003). Radiation therapy for intracranial germ cell tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 56(2), 511–18. -
Cortical ependymoma - A case report and review
Lehman, N. L., Jorden, M. A., Huhn, S. L., Barnes, P. D., Nelson, G. B., Fisher, P. G., & Horoupian, D. S. (2003). Cortical ependymoma - A case report and review. PEDIATRIC NEUROSURGERY, 39(1), 50–54. -
Biologic risk stratification of medulloblastoma: The real time is now
Fisher, P. G., Burger, P. C., & Eberhart, C. G. (2004). Biologic risk stratification of medulloblastoma: The real time is now. JOURNAL OF CLINICAL ONCOLOGY, 22(6), 971–974. -
Malignant gliomas in 2005 - Where to GO from here?
Fisher, P. G., & Buffler, P. A. (2005). Malignant gliomas in 2005 - Where to GO from here? JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 293(5), 615–617. -
Profile of daily life in children with brain tumors: An assessment of health-related quality of life
Bhat, S. R., Goodwin, T. L., Burwinkle, T. M., Lansdale, M. F., Dahl, G. V., Huhn, S. L., … Fisher, P. G. (2005). Profile of daily life in children with brain tumors: An assessment of health-related quality of life. JOURNAL OF CLINICAL ONCOLOGY, 23(24), 5493–5500. -
Etoposide, vincristine, and cyclosporin a with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: A pediatric oncology group Phase I study
Greenberg, M. L., Fisher, P. G., Freeman, C., Korones, D. N., Bernstein, M., Friedman, H., … Kretschmar, C. (2005). Etoposide, vincristine, and cyclosporin a with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: A pediatric oncology group Phase I study. PEDIATRIC BLOOD & CANCER, 45(5), 644–648. -
A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow transplantation
Minn, A. Y., Fisher, P. G., Barnes, P. D., & Dahl, G. V. (2007). A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow transplantation. PEDIATRIC BLOOD & CANCER, 48(2), 213–17. -
Advances toward an understanding of brainstem gliomas
Donaldson, S. S., Laningham, F., & Fisher, P. G. (2006). Advances toward an understanding of brainstem gliomas. JOURNAL OF CLINICAL ONCOLOGY, 24(8), 1266–72. -
Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: A children's oncology group phase II study
Korones, D. N., Fisher, P. G., Kretschmar, C., Zhou, T., Chen, Z., Kepner, J., & Freeman, C. (2008). Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: A children's oncology group phase II study. PEDIATRIC BLOOD & CANCER, 50(2), 227–230. -
Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family
Schiffman, J. D., Chun, N., Fisher, P. G., Dahl, G. V., Ford, J. M., & Eggerding, F. A. (2008). Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family. PEDIATRIC BLOOD & CANCER, 50(4), 914–16. -
Impaired human hippocampal neurogenesis after treatment for central nervous system
Monje, M. L., Vogel, H., Masek, M., Ligon, K. L., Fisher, P. G., & Palmer, T. D. (2007). Impaired human hippocampal neurogenesis after treatment for central nervous system. ANNALS OF NEUROLOGY, 62(5), 515–20. -
Update on new treatments and developments in childhood brain tumors
Partap, S., & Fisher, P. G. (2007). Update on new treatments and developments in childhood brain tumors. CURRENT OPINION IN PEDIATRICS, 19(6), 670–74. -
Family history of cancer among children with brain tumors - A critical review
Dearlove, J. V., Fisher, P. G., & Buffler, P. A. (2008). Family history of cancer among children with brain tumors - A critical review. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 30(1), 8–14. -
Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas
Balmaceda, C., Peereboom, D., Pannullo, S., Cheung, Y. K. K., Fisher, P. G., Alavi, J., … Fine, R. L. (2008). Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas. CANCER, 112(5), 1139–1146. -
Outcome analysis of childhood low-grade astrocytomas
Fisher, P. G., Tihan, T., Goldthwaite, P. T., Wharam, M. D., Carson, B. S., Weingart, J. D., … Burger, P. C. (2008). Outcome analysis of childhood low-grade astrocytomas. PEDIATRIC BLOOD & CANCER, 51(2), 245–50. -
Congenital glioblastoma multiforme: Case report and review of the literature
Hou, L. C., Bababeygy, S. R., Sarkissian, V., Fisher, P. G., Vogel, H., Barnes, P., & Huhn, S. L. (2008). Congenital glioblastoma multiforme: Case report and review of the literature. PEDIATRIC NEUROSURGERY, 44(4), 304–12. -
Levetiracetam For Seizures in Children With Brain Tumors and Other Cancers
Partap, S., & Fisher, P. G. (2009). Levetiracetam For Seizures in Children With Brain Tumors and Other Cancers. PEDIATRIC BLOOD & CANCER, 52(2), 288–89. -
Both Location and Age Predict Survival in Ependymoma: A SEER Study
McGuire, C. S., Sainani, K. L., & Fisher, P. G. (2009). Both Location and Age Predict Survival in Ependymoma: A SEER Study. PEDIATRIC BLOOD & CANCER, 52(1), 65–69. -
Gender Affects Survival for Medulloblastoma Only in Older Children and Adults: A Study From the Surveillance Epidemiology and End Results Registry
Curran, E. K., Sainani, K. L., Le, G. M., Propp, J. A., & Fisher, P. G. (2009). Gender Affects Survival for Medulloblastoma Only in Older Children and Adults: A Study From the Surveillance Epidemiology and End Results Registry. PEDIATRIC BLOOD & CANCER, 52(1), 60–64. -
Incidence patterns for ependymoma: a Surveillance, Epidemiology, and End Results study Clinical article
McGuire, C. S., Sainani, K. L., & Fisher, P. G. (2009). Incidence patterns for ependymoma: a Surveillance, Epidemiology, and End Results study Clinical article. JOURNAL OF NEUROSURGERY, 110(4), 725–29. -
Do children and adults differ in survival from medulloblastoma? A study from the SEER registry
Curran, E. K., Le, G. M., Sainani, K. L., Propp, J. M., & Fisher, P. G. (2009). Do children and adults differ in survival from medulloblastoma? A study from the SEER registry. JOURNAL OF NEURO-ONCOLOGY, 95(1), 81–85. -
Verbal memory impairments in children after cerebellar tumor resection
Kirschen, M. P., Davis-Ratner, M. S., Milner, M. W., Chen, S. H. A., Schraedley-Desmond, P., Fisher, P. G., & Desmond, J. E. (2008). Verbal memory impairments in children after cerebellar tumor resection. BEHAVIOURAL NEUROLOGY, 20(1-2), 39–53. -
Incidence Patterns of Central Nervous System Germ Cell Tumors A SEER Study
Goodwin, T. L., Sainani, K., & Fisher, P. G. (2009). Incidence Patterns of Central Nervous System Germ Cell Tumors A SEER Study. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 31(8), 541–44. -
Cerebrovascular disease in childhood cancer survivors A Children's Oncology Group Report
Morris, B., Partap, S., Yeom, K., Gibbs, I. C., Fisher, P. G., & King, A. A. (2009). Cerebrovascular disease in childhood cancer survivors A Children's Oncology Group Report. NEUROLOGY, 73(22), 1906–13. -
Neurological complications in children.
Partap, S., & Fisher, P. G. (2009). Neurological complications in children. Cancer Treatment and Research, 150, 133–43. -
Reproductive health issues in survivors of childhood and adult brain tumors.
Goodwin, T., Delasobera, B. E., & Fisher, P. G. (2009). Reproductive health issues in survivors of childhood and adult brain tumors. Cancer Treatment and Research, 150, 215–22. -
Medulloblastoma Incidence has not Changed Over Time A CBTRUS Study
Partap, S., Curran, E. K., Propp, J. M., Le, G. M., Sainani, K. L., & Fisher, P. G. (2009). Medulloblastoma Incidence has not Changed Over Time A CBTRUS Study. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 31(12), 970–71. -
Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas
Schiffman, J. D., Hodgson, J. G., VandenBerg, S. R., Flaherty, P., Polley, M.-Y. C., Yu, M., … James, C. D. (2010). Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas. CANCER RESEARCH, 70(2), 512–19. -
Intramedullary papillary ependymoma with choroid plexus differentiation and cerebrospinal fluid dissemination to the brain Case report
Dulai, M. S., Caccamo, D. V., Briley, A. L., Edwards, M. S. B., Fisher, P. C., & Lehman, N. L. (2010). Intramedullary papillary ependymoma with choroid plexus differentiation and cerebrospinal fluid dissemination to the brain Case report. JOURNAL OF NEUROSURGERY-PEDIATRICS, 5(5), 511–17. -
Birth Weight and Order as Risk Factors for Childhood Central Nervous System Tumors
Maclean, J., Partap, S., Reynolds, P., Von Behren, J., & Fisher, P. G. (2010). Birth Weight and Order as Risk Factors for Childhood Central Nervous System Tumors. JOURNAL OF PEDIATRICS, 157(3), 450–55. -
Liposomal cytarabine for central nervous system embryonal tumors in children and young adults
Partap, S., Murphy, P. A., Vogel, H., Barnes, P. D., Edwards, M. S. B., & Fisher, P. G. (2011). Liposomal cytarabine for central nervous system embryonal tumors in children and young adults. JOURNAL OF NEURO-ONCOLOGY, 103(3), 561–66. -
Dorsolateral Midbrain MRI Abnormalities and Ocular Motor Deficits Following Cytarabine-Based Chemotherapy for Acute Myelogenous Leukemia
Doan, T., Lacayo, N., Fisher, P. G., & Liao, Y. J. (2011). Dorsolateral Midbrain MRI Abnormalities and Ocular Motor Deficits Following Cytarabine-Based Chemotherapy for Acute Myelogenous Leukemia. JOURNAL OF NEURO-OPHTHALMOLOGY, 31(1), 52–53. -
Loss of SMARCB1/INI1 expression in poorly differentiated chordomas
Mobley, B. C., McKenney, J. K., Bangs, C. D., Callahan, K., Yeom, K. W., Schneppenheim, R., … Vogel, H. (2010). Loss of SMARCB1/INI1 expression in poorly differentiated chordomas. ACTA NEUROPATHOLOGICA, 120(6), 745–53. -
A Phase II Study of Metronomic Oral Topotecan for Recurrent Childhood Brain Tumors
Minturn, J. E., Janss, A. J., Fisher, P. G., Allen, J. C., Patti, R., Phillips, P. C., & Belasco, J. B. (2011). A Phase II Study of Metronomic Oral Topotecan for Recurrent Childhood Brain Tumors. PEDIATRIC BLOOD & CANCER, 56(1), 39–44. -
Hedgehogs, Flies, Wnts and MYCs: The Time Has Come for Many Things in Medulloblastoma
Monje, M., Beachy, P. A., & Fisher, P. G. (2011). Hedgehogs, Flies, Wnts and MYCs: The Time Has Come for Many Things in Medulloblastoma. JOURNAL OF CLINICAL ONCOLOGY, 29(11), 1395–1398. -
Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
Monje, M., Mitra, S. S., Freret, M. E., Raveh, T. B., Kim, J., Masek, M., … Beachy, P. A. (2011). Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 108(11), 4453–58. -
Neurological complications following treatment of children with brain tumors.
Monje, M., & Fisher, P. G. (2011). Neurological complications following treatment of children with brain tumors. Journal of Pediatric Rehabilitation Medicine, 4(1), 31–36. -
Birth Anomalies and Obstetric History as Risks for Childhood Tumors of the Central Nervous System
Partap, S., Maclean, J., Von Behren, J., Reynolds, P., & Fisher, P. G. (2011). Birth Anomalies and Obstetric History as Risks for Childhood Tumors of the Central Nervous System. PEDIATRICS, 128(3), E652–E657. -
The Eyes Have It! The Significance of Unilateral Ptosis
Lopez, J., & Fisher, P. G. (2012). The Eyes Have It! The Significance of Unilateral Ptosis. JOURNAL OF PEDIATRICS, 160(4), 703-? -
Cancer in Children with Nonchromosomal Birth Defects
Fisher, P. G., Reynolds, P., Von Behren, J., Carmichael, S. L., Rasmussen, S. A., & Shaw, G. M. (2012). Cancer in Children with Nonchromosomal Birth Defects. JOURNAL OF PEDIATRICS, 160(6), 978–83. -
Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design
Ho, T. W., Pearlman, E., Lewis, D., Hamalainen, M., Connor, K., Michelson, D., … Hewitt, D. J. (2012). Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. CEPHALALGIA, 32(10), 750–65. -
Complete Ocular Paresis in a Child with Posterior Fossa Syndrome
Afshar, M., Link, M., Edwards, M. S. B., Fisher, P. G., Fredrick, D., & Monje, M. (2012). Complete Ocular Paresis in a Child with Posterior Fossa Syndrome. PEDIATRIC NEUROSURGERY, 48(1), 51–54. -
Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors
Campen, C. J., Dearlove, J., Partap, S., Murphy, P., Gibbs, I. C., Dahl, G. V., & Fisher, P. G. (2012). Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors. JOURNAL OF NEURO-ONCOLOGY, 110(2), 287–91. -
50 years ago in The Journal of Pediatrics: the effect of degree of hypoxia on the electroencephalogram in infants.
Fisher, P. G. (2012). 50 years ago in The Journal of Pediatrics: the effect of degree of hypoxia on the electroencephalogram in infants. Journal of Pediatrics, 161(4), 614-? -
50 years ago in The Journal of Pediatrics: the surgical management of meningoceles and meningomyeloceles.
Lober, R. M., & Fisher, P. G. (2012). 50 years ago in The Journal of Pediatrics: the surgical management of meningoceles and meningomyeloceles. Journal of Pediatrics, 161(4), 734-? -
50 years ago in The Journal of Pediatrics: Sensory neuropathy in a child.
Fisher, P. G. (2012). 50 years ago in The Journal of Pediatrics: Sensory neuropathy in a child. Journal of Pediatrics, 161(6), 1034-? -
Anti-N-methyl-D-aspartate receptor encephalitis: what's in a name?
Campen, C. J., & Fisher, P. G. (2013). Anti-N-methyl-D-aspartate receptor encephalitis: what's in a name? Journal of Pediatrics, 162(4), 673–75. -
Changes in health status among aging survivors of pediatric upper and lower extremity sarcoma: a report from the childhood cancer survivor study.
Marina, N., Hudson, M. M., Jones, K. E., Mulrooney, D. A., Avedian, R., Donaldson, S. S., … Ness, K. K. (2013). Changes in health status among aging survivors of pediatric upper and lower extremity sarcoma: a report from the childhood cancer survivor study. Archives of Physical Medicine and Rehabilitation, 94(6), 1062–73. -
A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood.
Cohen, K. J., Gibbs, I. C., Fisher, P. G., Hayashi, R. J., Macy, M. E., & Gore, L. (2013). A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood. Neuro-Oncology, 15(6), 783–787. -
Prognostic role for diffusion-weighted imaging of pediatric optic pathway glioma.
Yeom, K. W., Lober, R. M., Andre, J. B., Fisher, P. G., Barnes, P. D., Edwards, M. S. B., & Partap, S. (2013). Prognostic role for diffusion-weighted imaging of pediatric optic pathway glioma. Journal of Neuro-Oncology, 113(3), 479–83. -
PARANEOPLASTIC OPSOCLONUS
Fisher, P. G., & Singer, H. S. (1995). PARANEOPLASTIC OPSOCLONUS. NEUROLOGY, 45(7), 1421–1421. -
ANTI-HU ANTIBODY IN A NEUROBLASTOMA-ASSOCIATED PARANEOPLASTIC-SYNDROME
Fisher, P. G., Wechsler, D. S., & Singer, H. S. (1994). ANTI-HU ANTIBODY IN A NEUROBLASTOMA-ASSOCIATED PARANEOPLASTIC-SYNDROME. PEDIATRIC NEUROLOGY, 10(4), 309–312. -
Third ventricular choroid plexus papilloma with psychosis - Case report
Carson, B. S., Weingart, J. D., Guarnieri, M., & Fisher, P. G. (1997). Third ventricular choroid plexus papilloma with psychosis - Case report. JOURNAL OF NEUROSURGERY, 87(1), 103–105. -
Salvage therapy after postoperative chemotherapy for primary brain tumors in infants and very young children
Fisher, P. G., Needle, M. N., Cnaan, A., Zhao, H. Q., Geyer, J. R., Molloy, P. T., … Phillips, P. C. (1998). Salvage therapy after postoperative chemotherapy for primary brain tumors in infants and very young children. CANCER, 83(3), 566–74. -
Rethinking brain tumors in babies and more
Fisher, P. G. (1998). Rethinking brain tumors in babies and more. ANNALS OF NEUROLOGY, 44(3), 300–302. -
Outcomes and failure patterns in childhood craniopharyngiomas
Fisher, P. G., Jenab, J., Goldthwaite, P. T., Tihan, T., Wharam, M. D., Foer, D. R., & Burger, P. C. (1998). Outcomes and failure patterns in childhood craniopharyngiomas. CHILDS NERVOUS SYSTEM, 14(10), 558–563. -
HAZARDOUS AIR POLLUTANTS AND RISK OF CHILDHOOD CENTRAL NERVOUS SYSTEM TUMORS IN CALIFORNIA
Fisher, P. G., Von Behren, J., Nelson, D. O., & Reynolds, P. (2012). HAZARDOUS AIR POLLUTANTS AND RISK OF CHILDHOOD CENTRAL NERVOUS SYSTEM TUMORS IN CALIFORNIA. Presented at the 15th International Symposium on Pediatric Neuro-Oncology (ISPNO), TORONTO,CANADA: OXFORD UNIV PRESS INC. -
In cyclosporine-induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire? Response
Minn, A. Y., Fisher, P. G., Barnes, P. D., & Dahl, G. V. (2008). In cyclosporine-induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire? Response. PEDIATRIC BLOOD & CANCER, 50(2), 427–427. -
50 Years Ago in THE JOURNAL OF PEDIATRICS A Critical Evaluation of Therapy of Febrile Seizures
Campen, C. J., & Fisher, P. G. (2010). 50 Years Ago in THE JOURNAL OF PEDIATRICS A Critical Evaluation of Therapy of Febrile Seizures. JOURNAL OF PEDIATRICS, 156(3), 449–49. -
Lessons learned from the clinical cooperative trials groups for childhood brain tumors
Fisher, P. G., Fry, T. J., & Wharam, M. D. (1998). Lessons learned from the clinical cooperative trials groups for childhood brain tumors. NEUROSURGERY QUARTERLY, 8(3), 216–231. -
Trends in the diagnosis and treatment of pediatric primary spinal cord tumors Clinical article
Gephart, M. G. H., Lober, R. M., Arrigo, R. T., Zygourakis, C. C., Guzman, R., Boakye, M., … Fisher, P. G. (2012). Trends in the diagnosis and treatment of pediatric primary spinal cord tumors Clinical article. JOURNAL OF NEUROSURGERY-PEDIATRICS, 10(6), 555–59. -
ASL CEREBRAL PERFUSION DIFFERENCES BETWEEN HIGH-GRADE AND LOW-GRADE PEDIATRIC BRAIN TUMORS
Campen, C. J., Soman, S., Fisher, P. G., Edwards, M. S., & Yeom, K. W. (2011). ASL CEREBRAL PERFUSION DIFFERENCES BETWEEN HIGH-GRADE AND LOW-GRADE PEDIATRIC BRAIN TUMORS. Presented at the 16th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO)/AANS/CNS Section on Tumors, CA: OXFORD UNIV PRESS INC. -
PSYCHIATRIC SYMPTOMS IN CHILDREN WITH MEDULLOBLASTOMA
Campen, C. J., Ashby, D., Fisher, P. G., & Monje, M. (2012). PSYCHIATRIC SYMPTOMS IN CHILDREN WITH MEDULLOBLASTOMA. Presented at the 15th International Symposium on Pediatric Neuro-Oncology (ISPNO), TORONTO,CANADA,CANADA: OXFORD UNIV PRESS INC. -
CONCURRENT CYCLOPHOSPHAMIDE AND CRANIOSPINAL RADIATION IN PEDIATRIC EMBRYONAL BRAIN TUMORS
Campen, C. J., & Fisher, P. G. (2011). CONCURRENT CYCLOPHOSPHAMIDE AND CRANIOSPINAL RADIATION IN PEDIATRIC EMBRYONAL BRAIN TUMORS. Presented at the 16th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO)/AANS/CNS Section on Tumors, CA: OXFORD UNIV PRESS INC. -
PSYCHIATRIC SYMPTOMS IN SURVIVORS OF CHILDHOOD GERM CELL TUMORS
Campen, C. J., Ashby, D., Fisher, P. G., & Monje, M. (2012). PSYCHIATRIC SYMPTOMS IN SURVIVORS OF CHILDHOOD GERM CELL TUMORS. Presented at the 15th International Symposium on Pediatric Neuro-Oncology (ISPNO), TORONTO,CANADA,CANADA: OXFORD UNIV PRESS INC. -
GENDER AND RACIAL RISK FACTORS FOR CHILDHOOD BRAIN TUMORS
Campen, C. J., Von Behren, J., Reynolds, P., & Fisher, P. G. (2012). GENDER AND RACIAL RISK FACTORS FOR CHILDHOOD BRAIN TUMORS. Presented at the 17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO), WASHINGTON,DC: OXFORD UNIV PRESS INC. -
PERIPHERAL NEUROBLASTIC TUMORS ARE DEVELOPMENTAL CANCERS THAT SEGREGATE BY AGE, HISTOLOGY, AND LOCATION
Effinger, K., Merrihew, L., & Fisher, P. (2013). PERIPHERAL NEUROBLASTIC TUMORS ARE DEVELOPMENTAL CANCERS THAT SEGREGATE BY AGE, HISTOLOGY, AND LOCATION. WILEY-BLACKWELL. -
DIVERGENT PATTERNS OF INCIDENCE IN PERIPHERAL NEUROBLASTIC TUMORS
Merrihew, L., Fisher, P., & Effinger, K. (2013). DIVERGENT PATTERNS OF INCIDENCE IN PERIPHERAL NEUROBLASTIC TUMORS. WILEY-BLACKWELL. -
Trends in the diagnosis and treatment of pediatric primary spinal cord tumors.
Hayden Gephart, M. G., Lober, R. M., Arrigo, R. T., Zygourakis, C. C., Guzman, R., Boakye, M., … Fisher, P. G. (2012). Trends in the diagnosis and treatment of pediatric primary spinal cord tumors. Journal of Neurosurgery. Pediatrics, 10(6), 555–59. -
HEALTH RELATED QUALITY OF LIFE IN PEDIATRIC BRAIN TUMOR PATIENTS: A COMPARISON OF PROTON AND PHOTON TREATED COHORTS
Kuhlthau, K., Bhat, S., Yeap, B. Y., Delahaye, J., Hill, K. S., Pulsifer, M., … Yock, T. I. (2012). HEALTH RELATED QUALITY OF LIFE IN PEDIATRIC BRAIN TUMOR PATIENTS: A COMPARISON OF PROTON AND PHOTON TREATED COHORTS. PEDIATRIC BLOOD & CANCER, 59(6), 979–979. -
AN OPEN-LABEL, TWO-STAGE, PHASE II STUDY OF BEVACIZUMAB AND LAPATINIB IN CHILDREN WITH RECURRENT OR REFRACTORY EPENDYMOMA: A COLLABORATIVE EPENDYMOMA RESEARCH NETWORK STUDY (CERN)
Dewire, M., Fouladi, M., Stewart, C., Wetmore, C., Hawkins, C., Jacobs, C., … Gajjar, A. (2013). AN OPEN-LABEL, TWO-STAGE, PHASE II STUDY OF BEVACIZUMAB AND LAPATINIB IN CHILDREN WITH RECURRENT OR REFRACTORY EPENDYMOMA: A COLLABORATIVE EPENDYMOMA RESEARCH NETWORK STUDY (CERN). Presented at the 2nd Annual Pediatric Neuro-Oncology Basic and Translational Research Conference, FORT LAUDERDALE,FL: OXFORD UNIV PRESS INC. -
Clinical Practice Guideline-Neurodiagnostic Evaluation of the Child With a Simple Febrile Seizure
Duffner, P. K., Berman, P. H., Baumann, R. J., Fisher, P. G., Green, J. L., & Schneider, S. (2011). Clinical Practice Guideline-Neurodiagnostic Evaluation of the Child With a Simple Febrile Seizure. PEDIATRICS, 127(2), 389–394. -
Relapse patterns in pediatric embryonal central nervous system tumors
Perreault, S., Lober, R. M., Carret, A.-S., Zhang, G., Hershon, L., Decarie, J.-C., … Partap, S. (2013). Relapse patterns in pediatric embryonal central nervous system tumors. JOURNAL OF NEURO-ONCOLOGY, 115(2), 209–15. -
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group
Gottardo, N. G., Hansford, J. R., McGlade, J. P., Alvaro, F., Ashley, D. M., Bailey, S., … Gajjar, A. (2014). Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. ACTA NEUROPATHOLOGICA, 127(2), 189–201. -
Surveillance imaging in children with malignant CNS tumors: low yield of spine MRI.
Perreault, S., Lober, R. M., Carret, A.-S., Zhang, G., Hershon, L., Décarie, J.-C., … Partap, S. (2014). Surveillance imaging in children with malignant CNS tumors: low yield of spine MRI. Journal of Neuro-Oncology, 116(3), 617–23. -
Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma.
Lober, R. M., Cho, Y.-J., Tang, Y., Barnes, P. D., Edwards, M. S., Vogel, H., … Yeom, K. W. (2014). Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma. Journal of Neuro-Oncology, 117(1), 175–82. -
Arterial spin-labeled perfusion of pediatric brain tumors.
Yeom, K. W., MITCHELL, L. A., Lober, R. M., Barnes, P. D., Vogel, H., Fisher, P. G., & Edwards, M. S. (2014). Arterial spin-labeled perfusion of pediatric brain tumors. AJNR. American Journal of Neuroradiology, 35(2), 395–401. -
MRI surrogates for molecular subgroups of medulloblastoma.
Perreault, S., Ramaswamy, V., Achrol, A. S., Chao, K., Liu, T. T., Shih, D., … Yeom, K. W. (2014). MRI surrogates for molecular subgroups of medulloblastoma. AJNR. American Journal of Neuroradiology, 35(7), 1263–1269. -
Subventricular spread of diffuse intrinsic pontine glioma.
Caretti, V., Bugiani, M., Freret, M., Schellen, P., Jansen, M., van Vuurden, D., … Monje, M. (2014). Subventricular spread of diffuse intrinsic pontine glioma. Acta Neuropathologica. -
Pilot undergraduate course teaches students about chronic illness in children: An educational intervention study.
Montenegro, R. E., Birnie, K. D., Fisher, P. G., Dahl, G. V., Binkley, J., & Schiffman, J. D. (2014). Pilot undergraduate course teaches students about chronic illness in children: An educational intervention study. Education for Health (Abingdon, England), 27(1), 34–38. -
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study.
Ahluwalia, M. S., Xie, H., Dahiya, S., Hashemi-Sadraei, N., Schiff, D., Fisher, P. G., … Peereboom, D. M. (2015). Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study. Journal of Neuro-Oncology, 122(1), 111–19. -
Quality of life outcomes in proton and photon treated pediatric brain tumor survivors
Yock, T. I., Bhat, S., Szymonifka, J., Yeap, B. Y., Delahaye, J., Donaldson, S. S., … Kuhlthau, K. A. (2014). Quality of life outcomes in proton and photon treated pediatric brain tumor survivors. RADIOTHERAPY AND ONCOLOGY, 113(1), 89–94. -
Risk of subsequent cancer following a primary CNS tumor
Strodtbeck, K., Sloan, A., Rogers, L., Fisher, P. G., Stearns, D., Campbell, L., & Barnholtz-Sloan, J. (2013). Risk of subsequent cancer following a primary CNS tumor. JOURNAL OF NEURO-ONCOLOGY, 112(2), 285–295. -
Brain Tumor Epidemiology - A Hub within Multidisciplinary Neuro-oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014
Woehrer, A., Lau, C. C., Prayer, D., Bauchet, L., Rosenfeld, M., Capper, D., … Barnholtz-Sloan, J. S. (2015). Brain Tumor Epidemiology - A Hub within Multidisciplinary Neuro-oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014. CLINICAL NEUROPATHOLOGY, 34(1), 40–46. -
Decreased tumor apparent diffusion coefficient correlates with objective response of pediatric low-grade glioma to bevacizumab
Hsu, C. H., Lober, R. M., Li, M. D., Partap, S., Murphy, P. A., Barnes, P. D., … Yeom, K. W. (2015). Decreased tumor apparent diffusion coefficient correlates with objective response of pediatric low-grade glioma to bevacizumab. JOURNAL OF NEURO-ONCOLOGY, 122(3), 491–96. -
An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)
DeWire, M., Fouladi, M., Turner, D. C., Wetmore, C., Hawkins, C., Jacobs, C., … Gajjar, A. (2015). An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN). JOURNAL OF NEURO-ONCOLOGY, 123(1), 85–91. -
Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
Goldman, S., Bouffet, E., Fisher, P. G., Allen, J. C., Robertson, P. L., Chuba, P. J., … Pollack, I. F. (2015). Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study. Journal of Clinical Oncology , 33(22), 2464–71. -
Divergent Patterns of Incidence in Peripheral Neuroblastic Tumors.
Merrihew, L. E., Fisher, P. G., & Effinger, K. E. (2015). Divergent Patterns of Incidence in Peripheral Neuroblastic Tumors. Journal of Pediatric Hematology/Oncology, 37(7), 502–6. -
in a patient with a complex connective tissue phenotype.
Zastrow, D. B., Zornio, P. A., Dries, A., Kohler, J., Fernandez, L., Waggott, D., … Wheeler, M. T. (2017). in a patient with a complex connective tissue phenotype. Cold Spring Harbor Molecular Case Studies, 3(1). -
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis
Ramaswamy, V., Hielscher, T., Mack, S. C., Lassaletta, A., Lin, T., Pajtler, K. W., … Taylor, M. D. (2016). Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis. JOURNAL OF CLINICAL ONCOLOGY, 34(21), 2468-? -
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study
Salloum, R., Hummel, T. R., Kumar, S. S., Dorris, K., Li, S., Lin, T., … Drissi, R. (2016). A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study. JOURNAL OF NEURO-ONCOLOGY, 129(3), 443–51. -
Phase 1 trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study
Lulla, R. R., Goldman, S., Yamada, T., Beattie, C. W., Bressler, L., Pacini, M., … Fouladi, M. (2016). Phase 1 trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study. NEURO-ONCOLOGY, 18(9), 1319–25. -
Child Neurology Residency-Finding the Right Fit.
Santoro, J. D., & Fisher, P. G. (2017). Child Neurology Residency-Finding the Right Fit. Pediatric Neurology, 67, 3–6. -
Disrupting the CD47-SIRP alpha anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
Gholamin, S., Mitra, S. S., Feroze, A. H., Liu, J., Kahn, S. A., Zhang, M., … Cheshier, S. H. (2017). Disrupting the CD47-SIRP alpha anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. SCIENCE TRANSLATIONAL MEDICINE, 9(381). -
Brain Perfusion and Diffusion Abnormalities in Children Treated for Posterior Fossa Brain Tumors.
Li, M. D., Forkert, N. D., Kundu, P., Ambler, C., Lober, R. M., Burns, T. C., … Yeom, K. W. (2017). Brain Perfusion and Diffusion Abnormalities in Children Treated for Posterior Fossa Brain Tumors. Journal of Pediatrics. -
The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease
Ramoni, R. B., Mulvihill, J. J., Adams, D. R., Allard, P., Ashley, E. A., Bernstein, J. A., … Wise, A. L. (2017). The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease. AMERICAN JOURNAL OF HUMAN GENETICS, 100(2), 185–92. -
R-SCAN: Imaging for Pediatric Minor Head Trauma.
Lee, S., Grant, G. A., Fisher, P. G., Imler, D., Padrez, R., Avery, C., … Wintermark, M. (2017). R-SCAN: Imaging for Pediatric Minor Head Trauma. Journal of the American College of Radiology , 14(2), 294–97. -
Sports and childhood brain tumors: Can I play?
Perreault, S., Lober, R. M., Davis, C., Stave, C., Partap, S., & Fisher, P. G. (2014). Sports and childhood brain tumors: Can I play? Neuro-Oncology Practice, 1(4), 158–65. -
R-SCAN: Imaging for Pediatric Simple Febrile Seizures.
Lee, S., Fisher, P., Grant, G. A., Porter, B., Dannenberg, B., & Wintermark, M. (2017). R-SCAN: Imaging for Pediatric Simple Febrile Seizures. Journal of the American College of Radiology . -
A New Approach to Rare Diseases of Children: The Undiagnosed Diseases Network.
Reuter, C. M., Brimble, E., DeFilippo, C., Dries, A. M., Enns, G. M., Ashley, E. A., … Wheeler, M. T. (2018). A New Approach to Rare Diseases of Children: The Undiagnosed Diseases Network. The Journal of Pediatrics. -
Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder
Olahova, M., Yoon, W. H., Thompson, K., Jangam, S., Fernandez, L., Davidson, J. M., … Wheeler, M. T. (2018). Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder. AMERICAN JOURNAL OF HUMAN GENETICS, 102(3), 494–504. -
It's Time for Pediatric Oncology to Grow Up.
Fisher, P. G. (2018). It's Time for Pediatric Oncology to Grow Up. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 36(10), 933–34. -
Pediatric neuro-oncology survival disparities in California
Cooney, T., Fisher, P. G., Tao, L., Clarke, C. A., & Partap, S. (2018). Pediatric neuro-oncology survival disparities in California. JOURNAL OF NEURO-ONCOLOGY, 138(1), 83–97. -
Long-term outcomes of primarily metastatic juvenile pilocytic astrocytoma in children
Yecies, D., Fisher, P. G., Cheshier, S., Edwards, M., & Grant, G. (2018). Long-term outcomes of primarily metastatic juvenile pilocytic astrocytoma in children. JOURNAL OF NEUROSURGERY-PEDIATRICS, 21(1), 49–53. -
50 Years Ago in The Journal of Pediatrics: Significance of Leukemia Clusters.
Fisher, P. G. (2018). 50 Years Ago in The Journal of Pediatrics: Significance of Leukemia Clusters. The Journal of Pediatrics, 198, 130. -
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
Robinson, G. W., Rudneva, V. A., Buchhalter, I., Billups, C. A., Waszak, S. M., Smith, K. S., … Northcott, P. A. (2018). Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. LANCET ONCOLOGY, 19(6), 768–84. -
CLINICAL, RADIOLOGICAL, PATHOLOGICAL AND MOLECULAR CHARACTERISTICS OF CHILDREN < 3 YEARS WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): A REPORT FROM THE INTERNATIONAL DIPG REGISTRY
Bartlett, A., Cochrane, A., Lane, A., Yanez-Escorza, N., Chaney, B., Doughman, R., … Fouladi, M. (2018). CLINICAL, RADIOLOGICAL, PATHOLOGICAL AND MOLECULAR CHARACTERISTICS OF CHILDREN < 3 YEARS WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): A REPORT FROM THE INTERNATIONAL DIPG REGISTRY. NEURO-ONCOLOGY, 20, 63. -
RECLASSIFICATION OF CENTRAL NERVOUS SYSTEM PRIMITIVE NEUROECTODERMAL TUMOR (CNS-PNET) INTO ENTITIES REFLECTS OUTCOME: RESULTS FROM THE PROSPECTIVE SJYC07 AND SJMB03 TRIALS
Liu, A., Orr, B., Lin, T., Hassall, T., Bowers, D. C., Bouffet, E., … Gajjar, A. (2018). RECLASSIFICATION OF CENTRAL NERVOUS SYSTEM PRIMITIVE NEUROECTODERMAL TUMOR (CNS-PNET) INTO ENTITIES REFLECTS OUTCOME: RESULTS FROM THE PROSPECTIVE SJYC07 AND SJMB03 TRIALS. NEURO-ONCOLOGY, 20, 71–72. -
INTRACRANIAL GROWING TERATOMA SYNDROME (IGTS): AN INTERNATIONAL RETROSPECTIVE STUDY
Michaiel, G., Strother, D., Gottardo, N., Bartels, U., Coltin, H., Eisenstat, D. D., … Lafay-Cousin, L. (2018). INTRACRANIAL GROWING TERATOMA SYNDROME (IGTS): AN INTERNATIONAL RETROSPECTIVE STUDY. NEURO-ONCOLOGY, 20, 88. -
CHARACTERISTICS OF PATIENTS >= 10 YEARS OF AGE WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY
Erker, C., Lane, A., Chaney, B., Escorza, N. Y., Fuller, C., Saab, R., … Fouladi, M. (2018). CHARACTERISTICS OF PATIENTS >= 10 YEARS OF AGE WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (IMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)
Robinson, G. W., Rudneva, V. A., Buchhalter, I., Billups, C. A., Waszak, S. M., Smith, K., … Northcott, P. A. (2018). THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (IMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07). NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
Surgical outcomes of pediatric spinal cord astrocytomas: systematic review and meta-analysis.
Azad, T. D., Pendharkar, A. V., Pan, J., Huang, Y., Li, A., Esparza, R., … Grant, G. A. (2018). Surgical outcomes of pediatric spinal cord astrocytomas: systematic review and meta-analysis. Journal of Neurosurgery. Pediatrics, 1–7. -
Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease.
Splinter, K., Adams, D. R., Bacino, C. A., Bellen, H. J., Bernstein, J. A., Cheatle-Jarvela, A. M., … Ashley, E. A. (2018). Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease. The New England Journal of Medicine. -
Congenital heart disease complexity and childhood cancer risk.
Collins, R. T., Von Behren, J., Yang, W., Carmichael, S. L., Reynolds, P., Fisher, P. G., & Shaw, G. M. (2018). Congenital heart disease complexity and childhood cancer risk. Birth Defects Research, 110(17), 1314–21. -
Long-term health and social function in adult survivors of paediatric astrocytoma: A report from the Childhood Cancer Survivor Study.
Effinger, K. E., Stratton, K. L., Fisher, P. G., Ness, K. K., Krull, K. R., Oeffinger, K. C., … Nathan, P. C. (2018). Long-term health and social function in adult survivors of paediatric astrocytoma: A report from the Childhood Cancer Survivor Study. European Journal of Cancer (Oxford, England : 1990), 106, 171–80. -
MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma.
Iv, M., Zhou, M., Shpanskaya, K., Perreault, S., Wang, Z., Tranvinh, E., … Yeom, K. W. (2018). MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma. AJNR. American Journal of Neuroradiology. -
Complementary medicines are not always complimentary in Down syndrome.
Fisher, P. G. (2018). Complementary medicines are not always complimentary in Down syndrome. The Journal of Pediatrics, 201, 2. -
Confused about what tests to order for altered mental status?
Fisher, P. G. (2018). Confused about what tests to order for altered mental status? The Journal of Pediatrics, 200, 2–3. -
Characteristics of undiagnosed diseases network applicants: implications for referring providers.
Walley, N. M., Pena, L. D., Hooper, S. R., Cope, H., Jiang, Y.-H. H., McConkie-Rosell, A., … Shashi, V. (2018). Characteristics of undiagnosed diseases network applicants: implications for referring providers. BMC Health Services Research, 18(1), 652. -
Further evidence for the involvement of EFL1 in a Shwachman-Diamond-like syndrome and expansion of the phenotypic features.
Tan, Q. K.-G., Cope, H., Spillmann, R. C., Stong, N., Jiang, Y.-H. H., McDonald, M. T., … Pena, L. D. (2018). Further evidence for the involvement of EFL1 in a Shwachman-Diamond-like syndrome and expansion of the phenotypic features. Cold Spring Harbor Molecular Case Studies, 4(5). -
A comprehensive iterative approach is highly effective in diagnosing individuals who are exome negative.
Shashi, V., Schoch, K., Spillmann, R., Cope, H., Tan, Q. K.-G., Walley, N., … Goldstein, D. B. (2018). A comprehensive iterative approach is highly effective in diagnosing individuals who are exome negative. Genetics in Medicine : Official Journal of the American College of Medical Genetics. -
Asymmetric tonsils or tonsillar cancer?
Fisher, P. G. (2018). Asymmetric tonsils or tonsillar cancer? The Journal of Pediatrics, 197, 3–4. -
Do race and socioeconomic status influence counseling at periviabilty?
Fisher, P. G. (2018). Do race and socioeconomic status influence counseling at periviabilty? The Journal of Pediatrics, 197, 2. -
Does fat or fat-free body mass drive neurodevelopment?
Fisher, P. G. (2018). Does fat or fat-free body mass drive neurodevelopment? The Journal of Pediatrics, 196, 2. -
Increased prescription drug use immediately after childhood cancer.
Fisher, P. G. (2018). Increased prescription drug use immediately after childhood cancer. The Journal of Pediatrics, 195, 4. -
Cystic periventricular leukomalacia: now you see it, now you don't?
Fisher, P. G. (2018). Cystic periventricular leukomalacia: now you see it, now you don't? The Journal of Pediatrics, 195, 2–3. -
In search of biomarkers for HIE.
Fisher, P. G. (2018). In search of biomarkers for HIE. The Journal of Pediatrics, 194, 3. -
Fertile ground for education on fertility preservation.
Fisher, P. G. (2018). Fertile ground for education on fertility preservation. The Journal of Pediatrics, 194, 1–2. -
Born too early for friends?
Fisher, P. G. (2018). Born too early for friends? The Journal of Pediatrics, 193, 2–3. -
Put down that smartphone and read to me!
Fisher, P. G. (2017). Put down that smartphone and read to me! The Journal of Pediatrics, 191, 1–2. -
Please diagnose infantile spasm early!
Fisher, P. G. (2017). Please diagnose infantile spasm early! The Journal of Pediatrics, 190, 3. -
Speak to me in English, Spanish, or both?
Fisher, P. G. (2017). Speak to me in English, Spanish, or both? The Journal of Pediatrics, 190, 1. -
Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases.
Pena, L. D., Jiang, Y.-H. H., Schoch, K., Spillmann, R. C., Walley, N., Stong, N., … Shashi, V. (2018). Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 20(4), 464–69. -
Do you know what SUDEP is?
Fisher, P. G. (2017). Do you know what SUDEP is? The Journal of Pediatrics, 188, 2. -
Remember to play and play to remember.
Fisher, P. G. (2017). Remember to play and play to remember. The Journal of Pediatrics, 188, 1. -
How mild is the outcome of mild neonatal encephalopathy?
Fisher, P. G. (2017). How mild is the outcome of mild neonatal encephalopathy? The Journal of Pediatrics, 187, 2–3. -
The next generation is here now.
Fisher, P. G. (2017). The next generation is here now. The Journal of Pediatrics, 185, 1–2. -
MARRVEL: Integration of Human and Model Organism Genetic Resources to Facilitate Functional Annotation of the Human Genome.
Wang, J., Al-Ouran, R., Hu, Y., Kim, S.-Y. Y., Wan, Y.-W. W., Wangler, M. F., … Bellen, H. J. (2017). MARRVEL: Integration of Human and Model Organism Genetic Resources to Facilitate Functional Annotation of the Human Genome. American Journal of Human Genetics, 100(6), 843–853. -
50 Years Ago in The Journal of Pediatrics: The Normal Achilles Tendon Reflex Time in Children as Measured with the Photomograph.
Fisher, P. G. (2017). 50 Years Ago in The Journal of Pediatrics: The Normal Achilles Tendon Reflex Time in Children as Measured with the Photomograph. The Journal of Pediatrics, 184, 44. -
Advancing the ball or holding the line in concussion?
Fisher, P. G. (2017). Advancing the ball or holding the line in concussion? The Journal of Pediatrics, 184, 1. -
A window into living with an undiagnosed disease: illness narratives from the Undiagnosed Diseases Network.
Spillmann, R. C., McConkie-Rosell, A., Pena, L., Jiang, Y.-H. H., Schoch, K., Walley, N., … Shashi, V. (2017). A window into living with an undiagnosed disease: illness narratives from the Undiagnosed Diseases Network. Orphanet Journal of Rare Diseases, 12(1), 71. -
Getting Published: A Primer on Manuscript Writing and the Editorial Process.
Fisher, P. G., Goodman, D. M., & Long, S. S. (2017). Getting Published: A Primer on Manuscript Writing and the Editorial Process. The Journal of Pediatrics, 185, 241–244. -
An Investigation of Connections between Birth Defects and Cancers Arising in Adolescence and Very Young Adulthood.
Von Behren, J., Fisher, P. G., Carmichael, S. L., Shaw, G. M., & Reynolds, P. (2017). An Investigation of Connections between Birth Defects and Cancers Arising in Adolescence and Very Young Adulthood. The Journal of Pediatrics, 185, 237–40. -
Does macrocephaly require MRI, CT, ultrasound, or a tape measure?
Fisher, P. G. (2017). Does macrocephaly require MRI, CT, ultrasound, or a tape measure? The Journal of Pediatrics, 182, 5. -
Talk with and not around the child.
Fisher, P. G. (2017). Talk with and not around the child. The Journal of Pediatrics, 182, 2. -
A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay.
Schoch, K., Meng, L., Szelinger, S., Bearden, D. R., Stray-Pedersen, A., Busk, O. L., … Shashi, V. (2017). A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay. American Journal of Human Genetics, 100(2), 343–351. -
A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3.
Chao, H.-T. T., Davids, M., Burke, E., Pappas, J. G., Rosenfeld, J. A., McCarty, A. J., … Malicdan, M. C. (2017). A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3. American Journal of Human Genetics, 100(1), 128–137. -
Newborns and red reflexes.
Fisher, P. G. (2016). Newborns and red reflexes. The Journal of Pediatrics, 179, 3. -
Just say no to opioids!
Fisher, P. G. (2016). Just say no to opioids! The Journal of Pediatrics, 179, 1. -
Extending precision to phenoytpes.
Fisher, P. G. (2016). Extending precision to phenoytpes. The Journal of Pediatrics, 178, 3–4. -
De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.
Shashi, V., Pena, L. D., Kim, K., Burton, B., Hempel, M., Schoch, K., … Kortüm, F. (2016). De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype. American Journal of Human Genetics, 99(4), 991–999. -
Shaken baby syndrome and abusive head trauma are real problems.
Fisher, P. G. (2016). Shaken baby syndrome and abusive head trauma are real problems. The Journal of Pediatrics, 177, 2. -
50 Years Ago in TheJournal ofPediatrics: Brain Scanning in Childhood.
Fisher, P. G. (2016). 50 Years Ago in TheJournal ofPediatrics: Brain Scanning in Childhood. The Journal of Pediatrics, 176, 113. -
Do we end life well?
Fisher, P. G. (2016). Do we end life well? The Journal of Pediatrics, 175, 1–4. -
Wandering can be dangerous.
Fisher, P. G. (2016). Wandering can be dangerous. The Journal of Pediatrics, 174, 3. -
Are neonatal stroke and hypoxic-ischemic encephalopathy related?
Fisher, P. G. (2016). Are neonatal stroke and hypoxic-ischemic encephalopathy related? The Journal of Pediatrics, 173, 1–3. -
Remember toxic exposures to antidementia drugs.
Fisher, P. G. (2016). Remember toxic exposures to antidementia drugs. The Journal of Pediatrics, 172, 1–4. -
Pay attention to when children start school!
Fisher, P. G. (2016). Pay attention to when children start school! The Journal of Pediatrics, 172, 1–4. -
50 Years Ago in The Journal of Pediatrics: Neonatal Myasthenia Gravis.
Fisher, P. G. (2016). 50 Years Ago in The Journal of Pediatrics: Neonatal Myasthenia Gravis. The Journal of Pediatrics, 171, 201. -
50 Years Ago in The Journal of Pediatrics: Hydrocephalus.
Fisher, P. G. (2015). 50 Years Ago in The Journal of Pediatrics: Hydrocephalus. The Journal of Pediatrics, 167(6), 1286. -
50 Years Ago in The Journal of Pediatrics: Treatment of Hydrocephalus with Acetazolamide: Results in 15 Cases.
Fisher, P. G. (2015). 50 Years Ago in The Journal of Pediatrics: Treatment of Hydrocephalus with Acetazolamide: Results in 15 Cases. The Journal of Pediatrics, 166(6), 1369. -
Early detection of cancer: past, present, and future.
Schiffman, J. D., Fisher, P. G., & Gibbs, P. (2015). Early detection of cancer: past, present, and future. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, 57–65. -
Brain Tumor Epidemiology - A Hub within Multidisciplinary Neuro-oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014.
Woehrer, A., Lau, C. C., Prayer, D., Bauchet, L., Rosenfeld, M., Capper, D., … Barnholtz-Sloan, J. S. (2014). Brain Tumor Epidemiology - A Hub within Multidisciplinary Neuro-oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014. Clinical Neuropathology, 34(1), 40–6. -
50 Years ago in the Journal of Pediatrics: brain tumors in early infancy--probably congenital in origin.
Fisher, P. G. (2014). 50 Years ago in the Journal of Pediatrics: brain tumors in early infancy--probably congenital in origin. The Journal of Pediatrics, 165(5), 978. -
50 years ago in the Journal of Pediatrics: cerebrospinal fluid and blood electrolytes in 62 mentally defective infants and children.
Fisher, P. G. (2014). 50 years ago in the Journal of Pediatrics: cerebrospinal fluid and blood electrolytes in 62 mentally defective infants and children. The Journal of Pediatrics, 165(3), 515. -
50 years ago in the Journal of Pediatrics: an etiologic and diagnostic study of cerebral palsy.
Fisher, P. G. (2014). 50 years ago in the Journal of Pediatrics: an etiologic and diagnostic study of cerebral palsy. The Journal of Pediatrics, 165(2), 273. -
50 Years ago in The Journal of Pediatrics: the hypotonic infant.
Fisher, P. G. (2014). 50 Years ago in The Journal of Pediatrics: the hypotonic infant. The Journal of Pediatrics, 164(3), 565. -
50 years ago in the Journal of Pediatrics: central nervous system complications of children with acute leukemia: an evaluation of treatment methods.
Fisher, P. G. (2014). 50 years ago in the Journal of Pediatrics: central nervous system complications of children with acute leukemia: an evaluation of treatment methods. The Journal of Pediatrics, 164(1), 33. -
50 Years ago in The Journal of Pediatrics: cigarettes, school children, and lung cancer.
Fisher, P. G. (2013). 50 Years ago in The Journal of Pediatrics: cigarettes, school children, and lung cancer. The Journal of Pediatrics, 163(5), 1371. -
In memoriam: Donald W. Lewis, MD (1951-2012 ).
Toor, S. S., & Fisher, P. G. (2012). In memoriam: Donald W. Lewis, MD (1951-2012 ). Journal of Child Neurology, 27(10), 1355–9. -
Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.
Bondy, M. L., Scheurer, M. E., Malmer, B., Barnholtz-Sloan, J. S., Davis, F. G., Il'yasova, D., … Buffler, P. A. (2008). Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer, 113(7 Suppl), 1953–68. -
Migrant mothers and risks of developmental disabilities in their children.
Fisher, P. G. (2019). Migrant mothers and risks of developmental disabilities in their children. The Journal of Pediatrics, 204, 2–3. -
Who is prescribing opioids to children with headaches?
Fisher, P. G. (2019). Who is prescribing opioids to children with headaches? The Journal of Pediatrics, 204, 1. -
Developing a genomics rotation: Practical training around variant interpretation for genetic counseling students.
Grove, M. E., White, S., Fisk, D. G., Rego, S., Dagan-Rosenfeld, O., Kohler, J. N., … Hanson-Kahn, A. K. (2019). Developing a genomics rotation: Practical training around variant interpretation for genetic counseling students. Journal of Genetic Counseling. -
A Patient with Sjogren's Syndrome and Subsequent Diagnosis of Inclusion Body Myositis and Light-Chain Amyloidosis.
Hom, J., Marwaha, S., Postolova, A., Kittle, J., Vasquez, R., Davidson, J., … Wheeler, M. (2019). A Patient with Sjogren's Syndrome and Subsequent Diagnosis of Inclusion Body Myositis and Light-Chain Amyloidosis. Journal of General Internal Medicine. -
Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review.
Kumar, A., Zastrow, D. B., Kravets, E. J., Beleford, D., Ruzhnikov, M. R., Grove, M. E., … Bernstein, J. A. (2019). Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review. American Journal of Medical Genetics. Part A. -
Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region.
Kelly, M. K., Park, M., Mihalek, I., Rochtus, A., Gramm, M., Pérez-Palma, E., … Poduri, A. (2019). Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region. Epilepsia, 60(3), 406–418. -
To sleep and dream without digital screens.
Fisher, P. G. (2019). To sleep and dream without digital screens. The Journal of Pediatrics, 205, 2. -
Have Zackery Lystedt concussion laws made an impact?
Fisher, P. G. (2019). Have Zackery Lystedt concussion laws made an impact? The Journal of Pediatrics, 206, 2–3. -
Point-of-care EEG?
Fisher, P. G. (2019). Point-of-care EEG? The Journal of Pediatrics, 207, 1. -
Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes.
Burrage, L. C., Reynolds, J. J., Baratang, N. V., Phillips, J. B., Wegner, J., McFarquhar, A., … Lee, B. (2019). Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes. American Journal of Human Genetics, 104(3), 422–438. -
A toolkit for genetics providers in follow-up of patients with non-diagnostic exome sequencing.
Zastrow, D. B., Kohler, J. N., Bonner, D., Reuter, C. M., Fernandez, L., Grove, M. E., … Wheeler, M. T. (2019). A toolkit for genetics providers in follow-up of patients with non-diagnostic exome sequencing. Journal of Genetic Counseling, 28(2), 213–28. -
Molecular Grouping and Outcomes of Young Children with Newly Diagnosed Ependymoma Treated on the Multi-Institutional SJYC07 Trial.
Upadhyaya, S. A., Robinson, G. W., Onar-Thomas, A., Orr, B. A., Billups, C. A., Bowers, D. C., … Gajjar, A. (2019). Molecular Grouping and Outcomes of Young Children with Newly Diagnosed Ependymoma Treated on the Multi-Institutional SJYC07 Trial. Neuro-Oncology. -
Long-term outcomes of primarily metastatic juvenile pilocytic astrocytoma in children.
Yecies, D., Fisher, P. G., Cheshier, S., Edwards, M., & Grant, G. (2018). Long-term outcomes of primarily metastatic juvenile pilocytic astrocytoma in children. Journal of Neurosurgery. Pediatrics, 21(1), 49–53. -
A toolkit for genetics providers in follow-up of patients with non-diagnostic exome sequencing
Zastrow, D. B., Kohler, J. N., Bonner, D., Reuter, C. M., Fernandez, L., Grove, M. E., … Zheng, A. (2019). A toolkit for genetics providers in follow-up of patients with non-diagnostic exome sequencing. JOURNAL OF GENETIC COUNSELING, 28(2), 213–28. -
Developing a genomics rotation: Practical training around variant interpretation for genetic counseling students
Grove, M. E., White, S., Fisk, D. G., Rego, S., Dagan-Rosenfeld, O., Kohler, J. N., … Hanson-Kahn, A. K. (2019). Developing a genomics rotation: Practical training around variant interpretation for genetic counseling students. JOURNAL OF GENETIC COUNSELING, 28(2), 466–76. -
Disproving junk science.
Fisher, P. G. (2019). Disproving junk science. The Journal of Pediatrics, 209, 1. -
IgG4-related disease: Association with a rare gene variant expressed in cytotoxic T cells.
Newman, J. H., Shaver, A., Sheehan, J. H., Mallal, S., Stone, J. H., Pillai, S., … Phillips, J. A. (2019). IgG4-related disease: Association with a rare gene variant expressed in cytotoxic T cells. Molecular Genetics & Genomic Medicine, e686. -
Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts.
Frésard, L., Smail, C., Ferraro, N. M., Teran, N. A., Li, X., Smith, K. S., … Montgomery, S. B. (2019). Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts. Nature Medicine. -
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro, J., Onar-Thomas, A., Young Poussaint, T., Wu, S., Ligon, A. H., Lindeman, N., … Fouladi, M. (2019). Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. The Lancet. Oncology. -
Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review
Kumar, A., Zastrow, D. B., Kravets, E. J., Beleford, D., Ruzhnikov, M. R. Z., Grove, M. E., … Zheng, A. (2019). Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 179(6), 966–77. -
A Patient with Sjogren's Syndrome and Subsequent Diagnosis of Inclusion Body Myositis and Light-Chain Amyloidosis
Hom, J., Marwaha, S., Postolova, A., Kittle, J., Vasquez, R., Davidson, J., … Wheeler, M. (2019). A Patient with Sjogren's Syndrome and Subsequent Diagnosis of Inclusion Body Myositis and Light-Chain Amyloidosis. JOURNAL OF GENERAL INTERNAL MEDICINE, 34(6), 1058–62. -
Heterozygous variants in MYBPC1 are associated with an expanded neuromuscular phenotype beyond arthrogryposis.
Shashi, V., Geist, J., Lee, Y., Yoo, Y., Shin, U., Schoch, K., … Kontrogianni-Konstantopoulos, A. (2019). Heterozygous variants in MYBPC1 are associated with an expanded neuromuscular phenotype beyond arthrogryposis. Human Mutation. -
A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B
Fangusaro, J., Onar-Thomas, A., Poussaint, T. Y., Wu, S., Ligon, A. H., Lindeman, N., … Dunkel, I. J. (2019). A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B. NEURO-ONCOLOGY, 21, 98–99. -
De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia.
Kanca, O., Andrews, J. C., Lee, P.-T., Patel, C., Braddock, S. R., Slavotinek, A. M., … Malicdan, M. C. (2019). De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia. American Journal of Human Genetics. -
Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy.
Bhatia, A., Mobley, B. C., Cogan, J., Koziura, M. E., Brokamp, E., Phillips, J., … Hamid, R. (2019). Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy. Clinical Imaging, 58, 108–113. -
Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification.
Nicoli, E.-R. R., Weston, M. R., Hackbarth, M., Becerril, A., Larson, A., Zein, W. M., … Malicdan, M. C. (2019). Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification. American Journal of Human Genetics, 104(6), 1127–1138. -
Genomics in medicine: a novel elective rotation for internal medicine residents.
Geng, L. N., Kohler, J. N., Levonian, P., Bernstein, J. A., Ford, J. M., Ahuja, N., … Wheeler, M. (2019). Genomics in medicine: a novel elective rotation for internal medicine residents. Postgraduate Medical Journal. -
Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing.
Reuter, C. M., Kohler, J. N., Bonner, D., Zastrow, D., Fernandez, L., Dries, A., … Wheeler, M. T. (2019). Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing. Journal of Genetic Counseling. -
Molecular correlates of cerebellar mutism syndrome in medulloblastoma.
Jabarkheel, R., Amayiri, N., Yecies, D., Huang, Y., Toescu, S., Nobre, L., … Ramaswamy, V. (2019). Molecular correlates of cerebellar mutism syndrome in medulloblastoma. Neuro-Oncology. -
50 Years Ago in The Journal of Pediatrics: The Clinical Spectrum and Early Diagnosis of Dawson's Encephalitis.
Fisher, P. G. (2019). 50 Years Ago in The Journal of Pediatrics: The Clinical Spectrum and Early Diagnosis of Dawson's Encephalitis. The Journal of Pediatrics, 213, 102. -
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial
Upadhyaya, S. A., Robinson, G. W., Onar-Thomas, A., Orr, B. A., Billups, C. A., Bowers, D. C., … Gajjar, A. (2019). Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial. NEURO-ONCOLOGY, 21(10), 1319–30. -
50 Years Ago in TheJournal ofPediatrics: The Coincidence of Neuroblastoma and Acute Cerebellar Encephalopathy.
Fisher, P. G. (2019). 50 Years Ago in TheJournal ofPediatrics: The Coincidence of Neuroblastoma and Acute Cerebellar Encephalopathy. The Journal of Pediatrics, 215, 117. -
How to evaluate concussion in all children?
Fisher, P. G. (2019). How to evaluate concussion in all children? The Journal of Pediatrics, 214, 1–3. -
VarSight: prioritizing clinically reported variants with binary classification algorithms.
Holt, J. M., Wilk, B., Birch, C. L., Brown, D. M., Gajapathy, M., Moss, A. C., … Worthey, E. A. (2019). VarSight: prioritizing clinically reported variants with binary classification algorithms. BMC Bioinformatics, 20(1), 496. -
De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Collosum, Axon, Cardiac, Ocular, and Genital Defects.
Accogli, A., Calabretta, S., St-Onge, J., Boudrahem-Addour, N., Dionne-Laporte, A., Joset, P., … Srour, M. (2019). De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Collosum, Axon, Cardiac, Ocular, and Genital Defects. American Journal of Human Genetics, 105(4), 854–868. -
Quality qualitative research for family-centered care.
Fisher, P. G. (2019). Quality qualitative research for family-centered care. The Journal of Pediatrics, 213, 1–3. -
De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia.
Kanca, O., Andrews, J. C., Lee, P.-T. T., Patel, C., Braddock, S. R., Slavotinek, A. M., … Malicdan, M. C. (2019). De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia. American Journal of Human Genetics, 105(3), 672–674. -
Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor ß Signaling.
Johnson, B. V., Kumar, R., Oishi, S., Alexander, S., Kasherman, M., Vega, M. S., … Jolly, L. A. (2019). Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor ß Signaling. Biological Psychiatry. -
De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation.
Mao, D., Reuter, C. M., Ruzhnikov, M. R., Beck, A. E., Farrow, E. G., Emrick, L. T., … Chao, H.-T. T. (2020). De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation. American Journal of Human Genetics. -
MR Imaging features of Diffuse Intrinsic Pontine Glioma (DIPG) and Relationship to Overall Survival: Report from the International DIPG Registry.
Leach, J. L., Roebker, J., Schafer, A., Baugh, J., Chaney, B., Fuller, C., … Jones, B. V. (2020). MR Imaging features of Diffuse Intrinsic Pontine Glioma (DIPG) and Relationship to Overall Survival: Report from the International DIPG Registry. Neuro-Oncology. -
Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science.
Schoch, K., Esteves, C., Bican, A., Spillmann, R., Cope, H., McConkie-Rosell, A., … Shashi, V. (2020). Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science. Genetics in Medicine : Official Journal of the American College of Medical Genetics. -
NON-DIPG PATIENTS ENROLLED IN THE INTERNATIONAL DIPG REGISTRY: HISTOPATHOLOGIC EVALUATION OF CENTRAL NEURO-IMAGING REVIEW
Lazow, M., Fuller, C., Lane, A., DeWire, M., Bandopadhayay, P., Bartels, U., … Leach, J. (2020). NON-DIPG PATIENTS ENROLLED IN THE INTERNATIONAL DIPG REGISTRY: HISTOPATHOLOGIC EVALUATION OF CENTRAL NEURO-IMAGING REVIEW. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
Outcome and molecular analysis of young children with choroid plexus carcinoma treated with non-myeloablative therapy: results from the SJYC07 trial.
Liu, A. P., Wu, G., Orr, B. A., Lin, T., Ashford, J. M., Bass, J. K., … Robinson, G. W. (2020). Outcome and molecular analysis of young children with choroid plexus carcinoma treated with non-myeloablative therapy: results from the SJYC07 trial. Neuro-Oncology Advances, 3(1), vdaa168. -
A STUDY OF LOW-DOSE CRANIOSPINAL RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AVERAGE-RISK MEDULLOBLASTOMA
Mochizuki, A., Janss, A., Partap, S., Fisher, P., Li, Y., Fisher, M., & Minturn, J. (2020). A STUDY OF LOW-DOSE CRANIOSPINAL RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AVERAGE-RISK MEDULLOBLASTOMA. NEURO-ONCOLOGY, 22, 390–91. -
MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA
Tam, L., Yecies, D., Han, M., Toescu, S., Wright, J., Mankad, K., … Yeom, K. (2020). MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
NON-DIPG PATIENTS ENROLLED IN THE INTERNATIONAL DIPG REGISTRY: HISTOPATHOLOGIC EVALUATION OF CENTRAL NEURO-IMAGING REVIEW
Lazow, M. A., Fuller, C., Lane, A., DeWire-Schottmiller, M. D., Bandopadhayay, P., Bartels, U., … Leach, J. L. (2020). NON-DIPG PATIENTS ENROLLED IN THE INTERNATIONAL DIPG REGISTRY: HISTOPATHOLOGIC EVALUATION OF CENTRAL NEURO-IMAGING REVIEW. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
RE-IRRADIATION OF DIPG: DATA FROM THE INTERNATIONAL DIPG REGISTRY
Lafay-Cousin, L., Lane, A., Schafer, A., Saab, R., Cheng, S., Bandopadhayay, P., … Strother, D. (2020). RE-IRRADIATION OF DIPG: DATA FROM THE INTERNATIONAL DIPG REGISTRY. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
PATTERNS OF CEREBROSPINAL FLUID DIVERSION AND SURVIVAL IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY
Cooney, T., DeWire-Schottmiller, M., Lane, A., Saab, R., Bandopadhayay, P., Dorris, K., … Warren, K. E. (2020). PATTERNS OF CEREBROSPINAL FLUID DIVERSION AND SURVIVAL IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases.
Kobren, S. N., Baldridge, D., Velinder, M., Krier, J. B., LeBlanc, K., Esteves, C., … Kohane, I. S. (2021). Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases. Genetics in Medicine : Official Journal of the American College of Medical Genetics. -
Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-Institutional Trials.
Upadhyaya, S. A., Robinson, G., Onar-Thomas, A., Orr, B. A., Johann, P., Wu, G., … Gajjar, A. (2021). Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-Institutional Trials. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. -
Functional and structural analysis of cytokine selective IL6ST defects that cause recessive hyper-IgE syndrome.
Chen, Y.-H., Zastrow, D. B., Metcalfe, R. D., Gartner, L., Krause, F., Morton, C. J., … Uhlig, H. H. (2021). Functional and structural analysis of cytokine selective IL6ST defects that cause recessive hyper-IgE syndrome. The Journal of Allergy and Clinical Immunology. -
Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain
Marbach, F., Stoyanov, G., Erger, F., Stratakis, C. A., Settas, N., London, E., … Schaaf, C. P. (2021). Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain. GENETICS IN MEDICINE. -
A resource of lipidomics and metabolomics data from individuals with undiagnosed diseases
Kyle, J. E., Stratton, K. G., Zink, E. M., Kim, Y.-M., Bloodsworth, K. J., Monroe, M. E., … Metz, T. O. (2021). A resource of lipidomics and metabolomics data from individuals with undiagnosed diseases. SCIENTIFIC DATA, 8(1), 114. -
Compound heterozygous KCTD7 variants in progressive myoclonus epilepsy.
Burke, E. A., Sturgeon, M., Zastrow, D. B., Fernandez, L., Prybol, C., Marwaha, S., … Malicdan, M. C. (2021). Compound heterozygous KCTD7 variants in progressive myoclonus epilepsy. Journal of Neurogenetics, 1–10. -
Radiomic Phenotypes Distinguish Atypical Teratoid/Rhabdoid Tumors from Medulloblastoma.
Zhang, M., Wong, S. W., Lummus, S., Han, M., Radmanesh, A., Ahmadian, S. S., … Yeom, K. W. (2021). Radiomic Phenotypes Distinguish Atypical Teratoid/Rhabdoid Tumors from Medulloblastoma. AJNR. American Journal of Neuroradiology. -
Diversity, Equity, and Inclusion in The Journal of Pediatrics.
Fisher, P. G., Long, S. S., Cole, C. R., Cohran, V. C., Fuentes-Afflick, E., Krantz, I., … Balistreri, W. F. (2021). Diversity, Equity, and Inclusion in The Journal of Pediatrics. The Journal of Pediatrics. -
SINGLE CELL RNA SEQUENCING FROM THE CSF OF SUBJECTS WITH H3K27M+DIPG/DMG TREATED WITH GD2 CAR T-CELLULAR THERAPY
Mochizuki, A., Ramakrishna, S., Good, Z., Patel, S., Chinnasamy, H., Yeom, K., … Monje, M. (2021). SINGLE CELL RNA SEQUENCING FROM THE CSF OF SUBJECTS WITH H3K27M+DIPG/DMG TREATED WITH GD2 CAR T-CELLULAR THERAPY. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
GD2 CAR T-CELLS MEDIATE CLINICAL ACTIVITY AND MANAGEABLE TOXICITY IN CHILDREN AND YOUNG ADULTS WITH H3K27M-MUTATED DIPG AND SPINAL CORD DMG
Majzner, R., Ramakrishna, S., Mochizuki, A., Patel, S., Chinnasamy, H., Yeom, K., … Monje, M. (2021). GD2 CAR T-CELLS MEDIATE CLINICAL ACTIVITY AND MANAGEABLE TOXICITY IN CHILDREN AND YOUNG ADULTS WITH H3K27M-MUTATED DIPG AND SPINAL CORD DMG. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
Genetic counselor roles in the undiagnosed diseases network research study: Clinical care, collaboration, and curation.
Kohler, J. N., Kelley, E. G., Boyd, B. M., Sillari, C. H., Marwaha, S., & Wheeler, M. T. (2021). Genetic counselor roles in the undiagnosed diseases network research study: Clinical care, collaboration, and curation. Journal of Genetic Counseling. -
GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas.
Majzner, R. G., Ramakrishna, S., Mochizuki, A., Patel, S., Chinnasamy, H., Yeom, K., … Monje, M. (2021). GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH. -
A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma.
Minturn, J. E., Mochizuki, A. Y., Partap, S., Belasco, J. B., Lange, B. J., Li, Y., … Janss, A. J. (2021). A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma. Frontiers in Oncology, 11, 744739. -
Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry.
Lazow, M. A., Fuller, C., DeWire, M., Lane, A., Bandopadhayay, P., Bartels, U., … Leach, J. L. (2021). Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry. Neuro-Oncology. -
50 Years Ago in TheJournalofPediatrics: Equity and Inclusion Are Not New Issues.
Fisher, P. G. (2021). 50 Years Ago in TheJournalofPediatrics: Equity and Inclusion Are Not New Issues. The Journal of Pediatrics, 239, 174. -
Equity and Inclusion Are Not New Issues
Fisher, P. G. (2021). Equity and Inclusion Are Not New Issues. JOURNAL OF PEDIATRICS, 239, 174. -
Radiomic Signatures of Posterior Fossa Ependymoma: Molecular Subgroups and Risk Profiles.
Zhang, M., Wang, E., Yecies, D., Tam, L. T., Han, M., Toescu, S., … Yeom, K. W. (2021). Radiomic Signatures of Posterior Fossa Ependymoma: Molecular Subgroups and Risk Profiles. Neuro-Oncology. -
Characteristics of patients =10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry.
Erker, C., Lane, A., Chaney, B., Leary, S., Minturn, J. E., Bartels, U., … Fouladi, M. (1800). Characteristics of patients =10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry. Neuro-Oncology, 24(1), 141–152. -
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Majzner, R. G., Ramakrishna, S., Yeom, K. W., Patel, S., Chinnasamy, H., Schultz, L. M., … Monje, M. (2022). GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature. -
Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study.
Fangusaro, J. R., Onar-Thomas, A., Poussaint, T. Y., Wu, S., Ligon, A. H., Lindeman, N. I., … Dunkel, I. J. (2022). Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. Neuro-Oncology. -
MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study.
Zhang, M., Wong, S. W., Wright, J. N., Wagner, M. W., Toescu, S., Han, M., … Yeom, K. W. (2022). MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study. Radiology, 212137. -
Characteristics of Children =36 Months of Age with Diffuse Intrinsic Pontine Glioma (DIPG): A Report from the International DIPG Registry.
Bartlett, A., Lane, A., Chaney, B., Escorza, N. Y., Black, K., Cochrane, A., … Fouladi, M. (2022). Characteristics of Children =36 Months of Age with Diffuse Intrinsic Pontine Glioma (DIPG): A Report from the International DIPG Registry. Neuro-Oncology. -
The Journal of Pediatrics Turns 90! A Perspective on Progress, Opportunities, and Challenges.
Balistreri, W. F., Daniels, S. R., Welch, T. R., Long, S. S., Jobe, A. H., deRegnier, R.-A., … Jewett, K. C. (2022). The Journal of Pediatrics Turns 90! A Perspective on Progress, Opportunities, and Challenges. The Journal of Pediatrics, 246, 235–241. -
MAJOR TUMOR REGRESSIONS IN H3K27M-MUTATED DIFFUSE MIDLINE GLIOMA (DMG) FOLLOWING SEQUENTIAL INTRAVENOUS (IV) AND INTRACEREBROVENTRICULAR (ICV) DELIVERY OF GD2-CAR T-CELLS
Monje, M., Majzner, R., Mahdi, J., Ramakrishna, S., Patel, S., Chinnasamy, H., … Mackall, C. (2022). MAJOR TUMOR REGRESSIONS IN H3K27M-MUTATED DIFFUSE MIDLINE GLIOMA (DMG) FOLLOWING SEQUENTIAL INTRAVENOUS (IV) AND INTRACEREBROVENTRICULAR (ICV) DELIVERY OF GD2-CAR T-CELLS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
PATTERNS OF CEREBROSPINAL FLUID DIVERSION AND SURVIVAL IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIFFUSE INTRINSIC PONTINE GLIOMA REGISTRY
Cooney, T., DeWire-Schottmiller, M., Lane, A., Saab, R., Bandopadhayay, P., Dorris, K., … Warren, K. (2022). PATTERNS OF CEREBROSPINAL FLUID DIVERSION AND SURVIVAL IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIFFUSE INTRINSIC PONTINE GLIOMA REGISTRY. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
A PHASE I TRIAL OF PANOBINOSTAT FOLLOWING RADIATION THERAPY IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) OR H3K27M-MUTATED THALAMIC DIFFUSE MIDLINE GLIOMA (DMG): REPORT FROM THE PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC-047)
Monje, M., Cooney, T., Glod, J., Huang, J., Baxter, P., Vinitsky, A., … Warren, K. E. (2022). A PHASE I TRIAL OF PANOBINOSTAT FOLLOWING RADIATION THERAPY IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) OR H3K27M-MUTATED THALAMIC DIFFUSE MIDLINE GLIOMA (DMG): REPORT FROM THE PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC-047). NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
Race, ethnicity, social determinants of health, and The Journal
Fisher, P. G. (2022). Race, ethnicity, social determinants of health, and The Journal. JOURNAL OF PEDIATRICS, 247, 1. -
Differential newborn DNA methylation among individuals with complex congenital heart defects and childhood lymphoma.
Richard, M. A., Yang, W., Sok, P., Li, M., Carmichael, S. L., von Behren, J., … Lupo, P. J. (2022). Differential newborn DNA methylation among individuals with complex congenital heart defects and childhood lymphoma. Birth Defects Research. -
Stereotactic radiosurgery for recurrent pediatric brain tumors: clinical outcomes and toxicity.
Wang, E., Gutkin, P. M., Oh, J., Pollom, E., Soltys, S. G., Grant, G. A., … Hiniker, S. M. (2022). Stereotactic radiosurgery for recurrent pediatric brain tumors: clinical outcomes and toxicity. Neurosurgical Focus, 53(5), E2. -
A concurrent dual analysis of genomic data augments diagnoses: experiences of two clinical sites in the Undiagnosed Diseases Network.
Spillmann, R. C., Tan, Q. K.-G., Reuter, C., Schoch, K., Kohler, J., Bonner, D., … Shashi, V. (2022). A concurrent dual analysis of genomic data augments diagnoses: experiences of two clinical sites in the Undiagnosed Diseases Network. Genetics in Medicine : Official Journal of the American College of Medical Genetics. -
When Can We Retire 3,600 cGy Craniospinal Irradiation in Medulloblastoma?
Fisher, P. G. (2023). When Can We Retire 3,600 cGy Craniospinal Irradiation in Medulloblastoma? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2300008. -
Major tumor regressions in H3K27M-mutated diffuse midline glioma (DMG) following sequential intravenous (IV) and intracerebroventricular (ICV) delivery of GD2-CAR T cells
Majzner, R. G., Mahdi, J., Ramakrishna, S., Patel, S., Chinnasamy, H., Yeom, K., … Mackall, C. L. (2022). Major tumor regressions in H3K27M-mutated diffuse midline glioma (DMG) following sequential intravenous (IV) and intracerebroventricular (ICV) delivery of GD2-CAR T cells. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH. -
Participation in a national diagnostic research study: assessing the patient experience.
Rosenfeld, L. E., LeBlanc, K., Nagy, A., Ego, B. K., & McCray, A. T. (2023). Participation in a national diagnostic research study: assessing the patient experience. Orphanet Journal of Rare Diseases, 18(1), 73. -
Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care.
Halley, M. C., Young, J. L., Tang, C., Mintz, K. T., Lucas-Griffin, S., Maghiro, A. S., … Tabor, H. K. (2023). Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care. The Journal of Pediatrics, 113537. -
High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse-Results from the SJYC07 trial and institutional experience.
Chiang, J., Bagchi, A., Li, X., Dhanda, S. K., Huang, J., Pinto, S. N., … Robinson, G. W. (2023). High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse-Results from the SJYC07 trial and institutional experience. Neuro-Oncology. -
Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care
Halley, M. C., Young, J. L., Tang, C., Mintz, K. T., Lucas-Griffin, S., Maghiro, A. S., … Undiagnosed Diseases Network. (2023). Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care. JOURNAL OF PEDIATRICS, 261. -
GABAERGIC NEURON-TO-GLIOMA SYNAPSES IN DIFFUSE MIDLINE GLIOMAS
Barron, T., Yalcin, B., Mochizuki, A., Cantor, E., Shamardani, K., Tlais, D., … Monje, M. (2023). GABAERGIC NEURON-TO-GLIOMA SYNAPSES IN DIFFUSE MIDLINE GLIOMAS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
HIGH-GRADE GLIOMA IN YOUNG CHILDREN IS HISTOLOGICALLY, MOLECULARLY, AND CLINICALLY DIVERSERESULTS FROM THE SJYC07 TRIAL AND INSTITUTIONAL EXPERIENCE
Chiang, J., Bagchi, A., Li, X., Dhanda, S. K., Huang, J., Pinto, S. N., … Robinson, G. W. (2023). HIGH-GRADE GLIOMA IN YOUNG CHILDREN IS HISTOLOGICALLY, MOLECULARLY, AND CLINICALLY DIVERSERESULTS FROM THE SJYC07 TRIAL AND INSTITUTIONAL EXPERIENCE. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC. -
Physician, patient, and caregiver support for a formal certification in pediatric neuro-oncology: A survey-based report from the SNO pediatrics working group.
Lindsay, H. B., Cheng, S., Fisher, P. G., Peters, K. B., Walsh, K. M., Ashley, D. M., & Huang, A. (2023). Physician, patient, and caregiver support for a formal certification in pediatric neuro-oncology: A survey-based report from the SNO pediatrics working group. Neuro-Oncology Advances, 5(1), vdad130. -
Arrhythmias including Atrial Fibrillation and Congenital Heart Disease in Kleefstra Syndrome: a possible epigenetic link.
Vasireddi, S. K., Draksler, T. Z., Bouman, A., Kummeling, J., Wheeler, M., Reuter, C., … Perez, M. V. (2024). Arrhythmias including Atrial Fibrillation and Congenital Heart Disease in Kleefstra Syndrome: a possible epigenetic link. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. -
Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy.
Donkervoort, S., Mohassel, P., O'Leary, M., Bonner, D. E., Hartley, T., Acquaye, N., … Bönnemann, C. G. (2024). Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy. Annals of Clinical and Translational Neurology. -
Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis.
Pucel, J., Briere, L. C., Reuter, C., Gochyyev, P., & LeBlanc, K. (2024). Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 101115. -
Immunological and hematological findings as major features in a patient with a new germline pathogenic CBL variant.
Stellacci, E., Carter, J. N., Pannone, L., Stevenson, D., Moslehi, D., Venanzi, S., … Martinelli, S. (2024). Immunological and hematological findings as major features in a patient with a new germline pathogenic CBL variant. American Journal of Medical Genetics. Part A, e63627. -
Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder.
Kohler, J. N., Legro, N. R., Baldridge, D., Shin, J., Bowman, A., Ugur, B., … Wheeler, M. T. (2024). Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 101166. -
Large-scale mutational analysis identifies UNC93B1 variants that drive TLR-mediated autoimmunity in mice and humans.
Rael, V. E., Yano, J. A., Huizar, J. P., Slayden, L. C., Weiss, M. A., Turcotte, E. A., … Barton, G. M. (2024). Large-scale mutational analysis identifies UNC93B1 variants that drive TLR-mediated autoimmunity in mice and humans. The Journal of Experimental Medicine, 221(8). -
The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for non-accepted ones.
Mulvihill, J. J., Findley, L., Ni, W., Sinsheimer, J. S., Cole, F. S., Esteves, C., … Mokry, J. R. (2024). The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for non-accepted ones. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 101203. -
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.
Hansford, J. R., Bouche, G., Ramaswamy, V., Jabado, N., Fonseca, A., Moloney, S., … Bouffet, E. (2024). Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2400709. -
SEQUENTIAL INTRAVENOUS AND INTRACEREBROVENTRICULAR GD2-CAR T-CELL THERAPY FOR H3K27M-MUTATED DIFFUSE MIDLINE GLIOMAS
Monje, M., Mahdi, J., Majzner, R. G., Yeom, K., Schultz, L. M., Richards, R., … Mackall, C. L. (2024). SEQUENTIAL INTRAVENOUS AND INTRACEREBROVENTRICULAR GD2-CAR T-CELL THERAPY FOR H3K27M-MUTATED DIFFUSE MIDLINE GLIOMAS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
- Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment
- Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
- Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma
- Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy
- Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
- Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
- Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas
Practice Locations
Stanford Neuroscience Health Center Palo Alto, CA
Palo Alto, CAStanford Neuroscience Health Center
213 Quarry Road
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records